The possible role of remnant-like particles as a risk factor for sudden cardiac death

Abstract Postmortem plasma lipid and lipoprotein levels were analyzed in two groups of Japanese subjects who died suddenly and unexpectedly due to cardiac (n = 93) or non-cardiac (n = 26) causes. No individuals in either group had a significant medical or cardiac history. In this study, we measured plasma total cholesterol, triglycerides, VLDL-cholesterol, LDL-cholesterol, HDL-cholesterol, and especially triglyceride-rich lipoprotein remnants. Triglyceride and apo E-rich remnant-like particles (RLP) were studied as a possible risk factor for sudden cardiac death in relation to the progression of coronary atherosclerosis. The receiver-operating characteristic curve (ROC) analysis showed that RLP-TG was the most significant risk factor for sudden cardiac death among the lipids and lipoproteins and RLP-C was the best predictor for coronary atherosclerosis. HDL-C and LDL-C levels were within normal limits in the majority of the cases and did not appear to relate to the sudden cardiac death. Apo E phenotyping was performed for the detection of the genetic background in the lipid metabolism. The frequency of the Apo E3/3 (wild type) phenotype, which closely relates with the remnant metabolism, was significantly reduced in the sudden cardiac death group. Our study on the postmortem plasma lipid analysis suggested that RLP-C and RLP-TG are the best risk predictor for coronary atherosclerosis and sudden cardiac death, respectively.

[1]  J. Enticknap Lipids in cadaver sera after fatal heart attacks , 1961, Journal of clinical pathology.

[2]  R. Havel,et al.  Characterization of subfractions of triglyceride-rich lipoproteins separated by gel chromatography from blood plasma of normolipemic and hyperlipemic humans. , 1972, Journal of lipid research.

[3]  S. Takeichi,et al.  Fluidity of cadaveric blood after sudden death: Part II: Mechanism of release of plasminogen activator from blood vessels , 1985, The American journal of forensic medicine and pathology.

[4]  K. Nakajima,et al.  A New Assay Method for Remnant Lipoproteins and Its Clinical Significance: -1) The Quantification of Serum RLP-C (remnant-like particle cholesterol) in a Fasting State-@@@―I. 空腹時血清RLP-C (remnant like particles-cholesterol)の測定法とその診断的有用性について― , 1992 .

[5]  T. Nikkari,et al.  Stability of plasma total cholesterol, triglycerides, and apolipoproteins B and A-I during the early postmortem period. , 1988, Journal of forensic sciences.

[6]  Kunio Ichikawa,et al.  REMNANT-LIKE PARTICLES IN VARIOUS LIVER DISEASES , 1991 .

[7]  A. Steinmetz Phenotyping of human apolipoprotein E from whole blood plasma by immunoblotting. , 1987, Journal of Lipid Research.

[8]  C. Sing,et al.  Apolipoprotein E polymorphism and atherosclerosis. , 1988, Arteriosclerosis.

[9]  S. Takeichi,et al.  Fluidity of cadaveric blood after sudden death: Part I Postmortem fibrinolysis and plasma catecholamine level , 1984, The American journal of forensic medicine and pathology.

[10]  T. Orchard,et al.  A Comparison of Blood Lipid and Lipoprotein Values in Young Adults Who Die Suddenly and Unexpectedly from Atherosclerotic Coronary Artery Disease With Other Noncardiac Deaths , 1995, The American journal of forensic medicine and pathology.

[11]  T. Sato,et al.  Effects of probucol on plasma lipids and lipoproteins in familial hypercholesterolemic patients with and without apolipoprotein E4. , 1990, Atherosclerosis.

[12]  K. Nakajima,et al.  Remnant‐like Particles and Restenosis of Coronary Arteries after PTCA , 1994, Annals of the New York Academy of Sciences.

[13]  J. Glanville Post-mortem Serum Cholesterol Levels , 1960, British medical journal.

[14]  D. Waters,et al.  Plasma Lipoproteins and Progression of Coronary Artery Disease Evaluated by Angiography and Clinical Events , 1993, Circulation.

[15]  J. Barboriak,et al.  Correlation of the extent of coronary occlusion with Apo B levels. Application of a new enzyme immunoassay technique for Apo B. , 1984, Atherosclerosis.

[16]  I. Tokunaga,et al.  Fluidity of cadaveric blood after sudden death: Part III. Acid-base balance and fibrinolysis. , 1984, The American journal of forensic medicine and pathology.

[17]  R. Havel,et al.  Prolonged postprandial responses of lipids and apolipoproteins in triglyceride-rich lipoproteins of individuals expressing an apolipoprotein epsilon 4 allele. , 1996, The Journal of clinical investigation.

[18]  Y. Matsuzawa,et al.  Increased frequency of lipoprotein disorders similar to type III hyperlipoproteinemia in survivors of myocardial infarction in Japan. , 1984, Atherosclerosis.

[19]  K. Nakajima,et al.  Uptake of remnant like particles (RLP) in diabetic patients from mouse peritoneal macrophages. , 1994, Journal of atherosclerosis and thrombosis.

[20]  R. Mahley,et al.  Structural and metabolic heterogeneity of beta-very low density lipoproteins from cholesterol-fed dogs and from humans with type III hyperlipoproteinemia. , 1982, Journal of lipid research.

[21]  J. Davignon,et al.  Triglycerides: a risk factor for coronary heart disease. , 1996, Atherosclerosis.

[22]  M. Barbir,et al.  High prevalence of hypertriglyceridaemia and apolipoprotein abnormalities in coronary artery disease. , 1988, British heart journal.

[23]  W. Willett,et al.  A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction. , 1991, The New England journal of medicine.

[24]  T. Lehtimäki Determination of apolipoprotein E phenotypes from stored or postmortem serum samples. , 1991, Clinica chimica acta; international journal of clinical chemistry.

[25]  R. Havel,et al.  Remnants of Lipoproteins of Intestinal and Hepatic Origin in Familial Dysbetalipoproteinemia , 1983, Arteriosclerosis.

[26]  T. Saito,et al.  An increase of serum remnant-like particles in non-insulin-dependent diabetic patients with microalbuminuria. , 1993, Clinica chimica acta; international journal of clinical chemistry.

[27]  K. Nakajima,et al.  Postprandial remnant-like particles and coronary artery disease , 1994 .

[28]  M. Zweig,et al.  Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. , 1993, Clinical chemistry.

[29]  M. Okazaki,et al.  High-performance liquid chromatography of serum lipoproteins. , 1986, Methods in enzymology.

[30]  R. Havel,et al.  Properties of an apolipoprotein E-enriched fraction of triglyceride-rich lipoproteins isolated from human blood plasma with a monoclonal antibody to apolipoprotein B-100. , 1992, Journal of lipid research.

[31]  R. Mahley,et al.  Familial dysbetalipoproteinemia. Abnormal binding of mutant apoprotein E to low density lipoprotein receptors of human fibroblasts and membranes from liver and adrenal of rats, rabbits, and cows. , 1981, The Journal of clinical investigation.

[32]  P. Hekali,et al.  Serum lipids in angiographically assessed coronary atherosclerosis. , 1978, Chest.

[33]  K. Nakajima,et al.  A new approach for the detection of type III hyperlipoproteinemia by RLP-cholesterol assay. , 1994, Journal of atherosclerosis and thrombosis.

[34]  K. Nakajima,et al.  Remnant-like lipoproteins stimulate whole blood platelet aggregation in vitro. , 1995, Thrombosis research.

[35]  J. Strong,et al.  Lipoproteins and apolipoproteins in postmortem serum. , 1988, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[36]  K. Nakajima,et al.  High postprandial plasma remnant-like particles-cholesterol in patients with coronary artery diseases on chronic maintenance hemodialysis. , 1996, Nihon Jinzo Gakkai shi.

[37]  K. Nakajima,et al.  Cholesterol in remnant-like lipoproteins in human serum using monoclonal anti apo B-100 and anti apo A-I immunoaffinity mixed gels. , 1993, Clinica chimica acta; international journal of clinical chemistry.

[38]  J. Fekete,et al.  The Use of Routine Laboratory Tests in Postmortem Examinations , 1974 .

[39]  I. Holme,et al.  High cholesterol and triglyceride values in Swedish males and females: increased risk of fatal myocardial infarction. First report from the AMORIS (Apolipoprotein related MOrtality RISk) study. , 1992, Blood pressure. Supplement.

[40]  H N NAUMANN,et al.  Postmortem liver function tests. , 1956, American journal of clinical pathology.

[41]  G. Assmann,et al.  Role of triglycerides in coronary artery disease: lessons from the Prospective Cardiovascular Münster Study. , 1992, The American journal of cardiology.

[42]  S. Shapiro,et al.  Association of coronary atherosclerosis with hyperapobetalipoproteinemia [increased protein but normal cholesterol levels in human plasma low density (beta) lipoproteins]. , 1980, Proceedings of the National Academy of Sciences of the United States of America.